Asthma control, severity, and quality of life: Quantifying the effect of uncontrolled disease

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 2, 2007, Pages 396-402

  Chen, Hubert ^a,b   Gould, Michael K ^c   Blanc, Paul D ^a   Miller, Dave P ^d   Kamath, Tripthi V ^b   Lee, June H ^b   Sullivan, Sean D ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GENENTECH INC   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Ovation Research Group   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Asthma control; disease severity; health status; quality of life; questionnaire

Indexed keywords

ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE CONTROL; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE;

ADULT; AGED; AGED, 80 AND OVER; ASTHMA; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 34547114768     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.04.040     Document Type: Article

References (35)

1. Vollmer W.M., Markson L.E., O'Connor E., Sanocki L.L., Fitterman L., Berger M., et al. Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med 160 (1999) 1647-1652
2. Vollmer W.M., Markson L.E., O'Connor E., Frazier E.A., Berger M., and Buist A.S. Association of asthma control with health care utilization: a prospective evaluation. Am J Respir Crit Care Med 165 (2002) 195-199
3. Cockcroft D.W., and Swystun V.A. Asthma control versus asthma severity. J Allergy Clin Immunol 98 (1996) 1016-1018
4. Joint Task Force on Practice Parameters, American Academy of Asthma, Allergy & Immunology, American College of Asthma, Allergy and Immunology, and Joint Council of Allergy, Asthma and Immunology. Attaining optimal asthma control: a practice parameter. J Allergy Clin Immunol 116 suppl (2005) S3-S11
5. Graham L.M. Classifying asthma. Chest 130 suppl (2006) 13S-20S
6. Stoloff S.W., and Boushey H.A. Severity, control, and responsiveness in asthma. J Allergy Clin Immunol 117 (2006) 544-548
7. Global Initiative for Asthma. Global strategy for asthma management and prevention (1995), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda (MD) (updated 2005). NIH publication no. 95-3659
8. Liard R., Leynaert B., Zureik M., Beguin F.X., and Neukirch F. Using Global Initiative for Asthma guidelines to assess asthma severity in populations. Eur Respir J 16 (2000) 615-620
9. Dolan C.M., Fraher K.E., Bleecker E.R., Borish L., Chipps B., Hayden M.L., et al. Design and baseline characteristics of The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol 92 (2004) 32-39
10. Juniper E.F., Guyatt G.H., Cox F.M., Ferrie P.J., and King D.R. Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J 14 (1999) 32-38
11. Ehrs P.O., Nokela M., Stallberg B., Hjemdahl P., and Wikstrom Jonsson E. Brief questionnaires for patient-reported outcomes in asthma: validation and usefulness in a primary care setting. Chest 129 (2006) 925-932
12. The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 16 (1990) 199-208
13. Dolan P. Modeling valuations for EuroQol health states. Med Care 35 (1997) 1095-1108
14. Shaw J.W., Johnson J.A., and Coons S.J. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 43 (2005) 203-220
15. Oppenheimer J.J., and Li J. Attaining asthma control. Curr Opin Allergy Clin Immunol 6 (2006) 119-123
16. Graham D.M., Blaiss M.S., Bayliss M.S., Espindle D.M., and Ware Jr. J.E. Impact of changes in asthma severity on health-related quality of life in pediatric and adult asthma patients: results from the asthma outcomes monitoring system. Allergy Asthma Proc 21 (2000) 151-158
17. Moy M.L., Israel E., Weiss S.T., Juniper E.F., Dube L., and Drazen J.M. Clinical predictors of health-related quality of life depend on asthma severity. Am J Respir Crit Care Med 163 (2001) 924-929
18. Juniper E.F., Guyatt G.H., Willan A., and Griffith L.E. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 47 (1994) 81-87
19. Rasanen P., Roine E., Sintonen H., Semberg-Konttinen V., Ryynanen O.P., and Roine R. Use of quality-adjusted life years for the estimation of effectiveness of health care: a systematic literature review. Int J Technol Assess Health Care 22 (2006) 235-241
20. Sznajder M., Aegerter P., Launois R., Merliere Y., Guidet B., and CubRea. A cost-effectiveness analysis of stays in intensive care units. Intensive Care Med 27 (2001) 146-153
21. Stahl E., Lindberg A., Jansson S.A., Ronmark E., Svensson K., Andersson F., et al. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes 3 (2005) 56
22. Al M.J., Koopmanschap M.A., van Enckevort P.J., Geertsma A., van der Bij W., de Boer W.J., et al. Cost-effectiveness of lung transplantation in The Netherlands: a scenario analysis. Chest 113 (1998) 124-130
23. Sollano J.A., Rose E.A., Williams D.L., Thornton B., Quint E., Apfelbaum M., et al. Cost-effectiveness of coronary artery bypass surgery in octogenarians. Ann Surg 228 (1998) 297-306
24. Cohen D.J., Taira D.A., Berezin R., Cox D.A., Morice M.C., Stone G.W., et al. Cost-effectiveness of coronary stenting in acute myocardial infarction: results from the stent primary angioplasty in myocardial infarction (stent-PAMI) trial. Circulation 104 (2001) 3039-3045
25. U.K. Prospective Diabetes Study Group. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care 22 (1999) 1125-1136
26. Ragnarson Tennvall G., and Apelqvist J. Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations. Diabetologia 44 (2001) 2077-2087
27. Oostenbrink J.B., Tangelder M.J., Busschbach J.J., van Hout B.A., Buskens E., Algra A., et al. Cost-effectiveness of oral anticoagulants versus aspirin in patients after infrainguinal bypass grafting surgery. J Vasc Surg 34 (2001) 254-262
28. de Wit G.A., Ramsteijn P.G., and de Charro F.T. Economic evaluation of end stage renal disease treatment. Health Policy 44 (1998) 215-232
29. Hazell M., Frank T., and Frank P. Health related quality of life in individuals with asthma related symptoms. Respir Med 97 (2003) 1211-1218
30. Szende A., Svensson K., Stahl E., Meszaros A., and Berta G.Y. Psychometric and utility-based measures of health status of asthmatic patients with different disease control level. Pharmacoeconomics 22 (2004) 537-547
31. Johnson J.A., Luo N., Shaw J.W., Kind P., and Coons S.J. Valuations of EQ-5D health states: are the United States and United Kingdom different?. Med Care 43 (2005) 221-228
32. Juniper E.F., Buist A.S., Cox F.M., Ferrie P.J., and King D.R. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest 115 (1999) 1265-1270
33. Marks G.B., Dunn S.M., and Woolcock A.J. A scale for the measurement of quality of life in adults with asthma. J Clin Epidemiol 45 (1992) 461-472
34. Barr J.T., Schumacher G.E., Freeman S., LeMoine M., Bakst A.W., and Jones P.W. American translation, modification, and validation of the St. George's Respiratory Questionnaire. Clin Ther 22 (2000) 1121-1145
35. Teeter J.G., and Bleecker E.R. Relationship between airway obstruction and respiratory symptoms in adult asthmatics. Chest 113 (1998) 272-277